
Search
Selected Filter
Filter Results
Displaying 1–10 of 520 news results
-
Jul 9, 2025
Atsena Gets FDA Nod to Expand XLRS Gene Therapy Clinical Trial to Include Pivotal Phase 3 Cohort
The expanded Phase 1/2/3 shortens time to potential FDA approval.
-
Jul 2, 2025
Stargardt Disease Research Advances
Recent developments in research on Stargardt disease.
-
Jul 2, 2025
Age-Related Macular Degeneration Research Advances
Recent developments in research on age-related macular degeneration.
-
Jul 2, 2025
Retinitis Pigmentosa Research Advances
Recent developments in research on retinitis pigmentosa.
-
Jul 2, 2025
Usher Syndrome Research Advances
Recent developments in research on Usher Syndrome.
-
Jul 2, 2025
Leber Congenital Amaurosis Research Advances
Recent developments in research on Leber congenital amaurosis.
-
Jun 24, 2025
In this in-depth interview hosted by InVivo, Jason Menzo, CEO of the Foundation Fighting Blindness, outlines the organization’s strategy for addressing significant changes and opportunities in the inherited retinal diseases (IRDs).
-
Jun 23, 2025
Opus Genetics secures up to $2M in non-dilutive funding from the RD Fund to advance its OPGx-MERTK gene therapy program targeting retinitis pigmentosa caused by MERTK mutations.
-
Jun 18, 2025
José-Alain Sahel Awarded 2026 ARVO Proctor Medal for Groundbreaking Research Achievements
Dr. Sahel’s research has led to several emerging retinal disease therapies that have moved into clinical trials.
-
Jun 13, 2025
Jason Menzo Urges Robust FY2026 Funding for National Eye Institute and Protection of Its Independent Status.